text_1: Diabetic patients with acute coronary syndrome experience increased short-term and long-term risk for bleeding events.
text_2: Among 6458 diabetic patients, platelet GP IIb/IIIa inhibition was associated with a significant mortality reduction at 30 days, from 6.2% to 4.6% (OR 0.74; 95% CI 0.59 to 0.92; P=0.007).